antibody
[대역어] 항체
[용어속성] Protein
[용어속성] Protein
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Research
[키워드] ACE2
ACE2 binding
antibody
bind
binding domain
cause
Cell
complex
coronavirus
CR3022
cryo-EM
crystal structure
epitope
fusion
H11-H4
human Angiotensin-converting enzyme
Influenza
Interaction
maturation
nanobodies
nanobody
neutralization
Neutralizing activity
overlap
produced
RBD
receptor
recognize
SARS-CoV-2
SARS-CoV-2 receptor
SARS-CoV-2 Spike RBD
SARS-CoV-2 virus
spike trimer
the spike protein
viral entry
[DOI] 10.1038/s41594-020-0469-6 [Article Type] Research
[DOI] 10.1038/s41594-020-0469-6 [Article Type] Research
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 24 hour
48 hour
Activation
acute lung injury
acute pneumonia
acute respiratory distress syndrome
Administered
Adult
age
all-cause mortality
Amendment
antibodies
antibody
Antibody test
anticipated
antiviral therapy
approval
ARDS
assessment
assigned
baseline
Biomarker
Blood
cardiac disease
Care
change
class
Clinical improvement
clinical study
clinical trial
complement
Complement inhibitor
component
Computed tomography
concealed
Concentration
conducted
Confirmed
Controlled
coronary syndrome
COVID-19
criteria
current
Day
diagnosis of SARS-CoV-2
dialysis
discharge
dissemination
dose
Duration
Efficacy
element
eligibility
Endotracheal intubation
EU Clinical Trial
EudraCT
evaluate the effect
expected
failure
female patient
Final
fraction
France
Germany
greater
half-live
hospital
Hospitalization
humanized
Hypercoagulable state
Immunoglobulin
Infection
Inflammatory
inhibitor
initiated
intensive care
Intubated
intubation
invasive
Invasive mechanical ventilation
investigator
IVIG
Japan
Lung injury
mechanical ventilation
medication
monoclonal
multicenter
Neisseria meningitidis
Non-invasive
number
objective
Open-label
original
outcome
oxygen
participant
Patient
patients randomized
patients with COVID-19
Period
peripheral capillary
phase
Placebo
Pneumonia
polymerase chain
positive airway pressure
presenting
progression
protocol
randomised
randomised controlled trial
randomization
randomization list
Randomized
randomized controlled study
Randomly
Ravulizumab
receive
recruitment
registry
Remdesivir
renal
respiratory
respiratory distress
Respiratory distress syndrome
routine clinical care
Safety
screened
Screening
secondary
Serious Adverse Events
serum
severe acute respiratory distress syndrome coronavirus 2
Severe acute respiratory syndrome
severe COVID-19
severe pneumonia
SOFA
Spain
SpO2
Sponsor
stratified
Study protocol
supportive care
survival
The United States
therapy
time
Treatment
treatment-emergent adverse event
Ultomiris
United Kingdom
ventricular
Viral
website
with COVID-19
X-ray
[DOI] 10.1186/s13063-020-04548-z PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04548-z PMC 바로가기 [Article Type] Letter
SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients
Original Article
[키워드] antibody
clinically
collected
Contamination
coronavirus
COVID‐19
COVID‐19 patient
COVID‐19 patients
COVID‐19
Critical
diagnoses
greater
healthcare worker
hospital
Humoral immunity
ICU
increased risk
initial
intensive care unit
involved
Isolation
nine
Patient
patients
positive
proximal
Result
risk
RNA
SARS‐CoV‐2
SARS‐CoV‐2
serum antibodies
serum antibody
severe disease
swabs
the patient
Transmission
utility
viral clearance
Viral RNA
while
[DOI] 10.1111/irv.12783 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1111/irv.12783 PMC 바로가기 [Article Type] Original Article
Flare of Antiphospholipid Syndrome in the Course of COVID-19
Case Report
[키워드] acute respiratory syndrome
antibody
anticoagulation
Antiphospholipid syndrome
catastrophic
conditions
coronavirus disease
Coronavirus-2
Course
COVID-19
Endothelium
flare
hemorrhage
Hydroxychloroquine
increased risk
Infection
Inflammatory
Ischemia
limb
prothrombotic
responsible
suffered
syndrome
thrombosis
Venous Thromboembolism
[DOI] 10.1055/s-0040-1716735 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1055/s-0040-1716735 PMC 바로가기 [Article Type] Case Report
Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report
Case Report
[키워드] anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
antibody
B cell
Case report
cause
caused
Chest computed tomography
coronavirus disease
COVID-19
detect
determine
discharge
discharged
discharged patient
elevated
excluded
Extend isolation time
ferritin
hospital
hospitals
humoral immune response
immunodeficiency
Infection
Isolation
lesion
Lymphocyte count
measure
Mutation
New corona virus
New coronavirus
non-infectious
occur
Organizing pneumonia
oropharyngeal swab
Patient
Pneumonia
positive
progression
protective antibodies
public health threat
Pulmonary infection
recovered patient
recurrence
Recurrent
reduced
responsible
SARS-CoV-2
Sequencing
Serological testing
specific antibody
Spread
suffered
the epidemic
Total
triggered
TRNT1
virus
World Health Organization
[DOI] 10.1186/s12879-020-05231-z PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s12879-020-05231-z PMC 바로가기 [Article Type] Case Report
Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study
Neurology
[키워드] age
analyzed
antibody
Brain
case sery
Central nervous system
Cerebrovascular disease
collected
Comorbidity
Complication
coronavirus disease
COVID-19
Critically ill
Critically ill patient
critically ill patients
delirium
demographic
exhibited
hemoglobin
Ill
Injury
intensive care
involved
Laboratory
male
manifestation
multiple organ
neurological
Neurological complication
neurological manifestations
neuromuscular disease
neuromuscular diseases
Patient
physician
Prevalence
retrospective
significantly higher
single-center
stroke
Symptom
the mean
Tongji Hospital
Treatment
with COVID-19
Wuhan, China
[DOI] 10.3389/fneur.2020.00806 PMC 바로가기 [Article Type] Neurology
[DOI] 10.3389/fneur.2020.00806 PMC 바로가기 [Article Type] Neurology
Adaptive immunity to SARS-CoV-2
Review Article
[키워드] absence
Activation
acute infection
acute respiratory syndrome
Adaptive immunity
antibody
Antibody Response
Antibody titre
blood vessels
CD4
CD8
Clinical use
common cold
coronavirus
Correlate of protection
Course
COVID-19
cross-reactivity
Cytokines
detectable
disease
disease severity
duration of exposure
epitope
Evidence
expression
full recovery
functional
human coronavirus
human coronaviruses
Hyperinflammatory
IL-6
immune memory
immunogenic
immunology
immunopathological
immunopathology
individual
Infection
kidney
lung
majority
mechanism
neutralizing antibody
neutralizing monoclonal antibody
offer
Pathogenesis
Protective
question
raised
rapid progress
response
SARS-CoV-2
serum biomarker
severe cases
susceptibility
symptomatic disease
Symptoms
T cell
T-cell
T-cell immunity
therapeutic target
tissue damage
Vaccine
viral antigens
Viral load
Virus neutralization
while
[DOI] 10.1093/oxfimm/iqaa003 PMC 바로가기 [Article Type] Review Article
[DOI] 10.1093/oxfimm/iqaa003 PMC 바로가기 [Article Type] Review Article
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
Article
[키워드] antibodies
antibody
COVID-19 epidemic
cumulative
determine
diagnosed with COVID-19
Epidemiology
Evidence
HCW
Health care
Health care worker
high-risk population
hospital
IgA
IgG
IgM
Infection
participant
Patient
positive
Prevalence
proportion
random
recruited
rRT-PCR
rRT-PCR testing
SARS-CoV-2
SARS-COV-2 infection
seropositive
Seroprevalence
Spain
Spanish
viral infection
[DOI] 10.1038/s41467-020-17318-x PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-020-17318-x PMC 바로가기 [Article Type] Article
Serological differentiation between COVID-19 and SARS infections
COVID-19와 SARS 감염의 혈청학적 구별
Research Article
[키워드] acute disease
anti-N antibodies
Anti-RBD antibodies
antibody
antibody tests
asymptomatic infection rate
asymptomatic infection rates
best
Betacoronavirus
Blood
capture
caused
choice
Contact tracing
Coronaviridae
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 antibody test
COVID-19 antibody tests
cross-reactivity
diagnostic
diagnostic test
diagnostic tests
Disease diagnosis
ELISA
family Coronaviridae
genus
genus Betacoronavirus
herd immunity
humans
Immunity
infect
Infection
N protein
offer
other coronavirus
outbreak
PCR
PCR test
PCR tests
performed
protective immunity
Protein
RBD region
required
SARS
SARS infection
SARS patient
SARS-CoV
SARS-CoV-2
sequence identity
sera
serological test
Serological tests
serology
significant level
species
specificity
survivor
virus
waned
while
[DOI] 10.1080/22221751.2020.1780951 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1080/22221751.2020.1780951 PMC 바로가기 [Article Type] Research Article